OA
MDT icon

Oxbow Advisors’s Medtronic MDT Stock Holding History

Oxbow Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,022
Closed -$438K – 236
2024
Q1 		$438K Sell
5,022
-50,942
-91% -$4.35M 0.06% 136
2023
Q4 		$4.61M Sell
55,964
-1,155
-2% -$88K 0.7% 39
2023
Q3 		$4.48M Buy
+57,119
New +$4.78M 0.7% 36
2022
Q3 		– Sell
-6,323
Closed -$567K – 249
2022
Q2 		$567K Sell
6,323
-665
-10% -$67.4K 0.08% 156
2022
Q1 		$775K Buy
6,988
+100
+1% +$10.6K 0.08% 137
2021
Q4 		$713K Buy
6,888
+1,052
+18% +$122K 0.07% 152
2021
Q3 		$732K Sell
5,836
-2,116
-27% -$274K 0.07% 162
2021
Q2 		$987K Hold
7,952
– – 0.1% 141
2021
Q1 		$939K Sell
7,952
-790
-9% -$92.6K 0.11% 135
2020
Q4 		$1.02M Sell
8,742
-501
-5% -$55.2K 0.13% 120
2020
Q3 		$961K Buy
9,243
+28
+0.3% +$2.81K 0.12% 129
2020
Q2 		$845K Sell
9,215
-19,909
-68% -$1.91M 0.12% 139
2020
Q1 		$2.63M Buy
29,124
+12,808
+78% +$1.36M 0.44% 61
2019
Q4 		$1.85M Buy
16,316
+1,274
+8% +$140K 0.21% 102
2019
Q3 		$1.63M Sell
15,042
-1,450
-9% -$151K 0.22% 103
2019
Q2 		$1.61M Sell
16,492
-590
-3% -$53.9K 0.19% 114
2019
Q1 		$1.56M Buy
17,082
+2,510
+17% +$225K 0.19% 113
2018
Q4 		$1.32M Sell
14,572
-13,901
-49% -$1.3M 0.18% 115
2018
Q3 		$2.8M Sell
28,473
-235
-0.8% -$21.7K 0.34% 77
2018
Q2 		$2.46M Buy
28,708
+1,820
+7% +$152K 0.31% 84
2018
Q1 		$2.16M Sell
26,888
-520
-2% -$42.9K 0.44% 68
2017
Q4 		$2.21M Buy
27,408
+1,934
+8% +$155K 0.41% 72
2017
Q3 		$1.98M Sell
25,474
-1,568
-6% -$130K 0.38% 78
2017
Q2 		$2.4M Buy
27,042
+7,790
+40% +$657K 0.42% 75
2017
Q1 		$1.55M Buy
+19,252
New +$1.5M 0.25% 101

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Oxbow Advisors's MDT Position: Q2 2024 in Review

Oxbow Advisors sold out of Medtronic (MDT) in Q2 2024, closing a stake of 5,022 shares — an estimated $438K sold.

Oxbow Advisors first reported a position in MDT in Q1 2017 and held it in 25 quarters. The position peaked at $4.61M in Q4 2023. 2,029 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Oxbow Advisors reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • Oxbow Advisors sold 5,022 Medtronic shares in Q2 2024, an estimated $438K.
  • Oxbow Advisors first reported a position in Medtronic in Q1 2017 and held it in 25 quarters.
  • Oxbow Advisors's Medtronic position peaked at $4.61M in Q4 2023.
  • 2,029 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Oxbow Advisors's 13F filing for Q2 2024, filed 6 Aug 2024.